Better Dividend King to Buy and Hold: Johnson & Johnson or Kenvue?

Published September 18, 2026 · Category: Finance

Overview

Dividend investors looking for a defensive healthcare candidate will likely come across companies like Johnson & Johnson (NYSE: JNJ) and Kenvue (NYSE: KVUE), and the next natural question is which one deserves a permanent spot in a dividend portfolio.

Granted, one could compare dividend yields, payout ratios, and other related metrics and be done with all of it. But it's the company itself that deserves a deeper look, because other factors -- like acquisitions, legal settlements, and the company's growth trajectory -- can complicate matters.

Details

So let's dive into which stock better deserves a spot in your portfolio.

Continue reading

Source

Originally published at www.fool.com.

Related Articles

• Bank of Japan raises interest rates to 31-year high, flags concerns over inflation
• Where Will CRISPR Therapeutics Be in 10 Years if Gene Editing Fulfills Its Promise?
• UN mission finds evidence signaling U.S. war crimes in Iran; Washington rejects report